pH-dependent anticancer drug release from silk nanoparticles.
about
Silk fibroin-based nanoparticles for drug deliveryChemical basis of interactions between engineered nanoparticles and biological systemsEngineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic DeliveryModulation of vincristine and doxorubicin binding and release from silk filmsSpatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles.Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model.Hydrophobic drug-triggered self-assembly of nanoparticles from silk-elastin-like protein polymers for drug deliverySilk as an innovative biomaterial for cancer therapyFocal therapy of neuroblastoma using silk films to deliver kinase and chemotherapeutic agents in vivo.Silk-based stabilization of biomacromolecules.Doxorubicin loaded nanodiamond-silk spheres for fluorescence tracking and controlled drug release.The method of purifying bioengineered spider silk determines the silk sphere properties.Silk scaffolds for musculoskeletal tissue engineering.Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma.Silk-elastin-like protein biomaterials for the controlled delivery of therapeutics.A sight on protein-based nanoparticles as drug/gene delivery systems.Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment.Antitumor properties of platinum(iv) prodrug-loaded silk fibroin nanoparticles.Recent progress on nanoparticle-based drug delivery systems for cancer therapy.Drug release from core-shell PVA/silk fibroin nanoparticles fabricated by one-step electrospraying.Silk Materials Functionalized via Genetic Engineering for Biomedical Applications.Silk nanoparticles: from inert supports to bioactive natural carriers for drug delivery.Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells.Metabolic Reprogramming of Macrophages Exposed to Silk, Poly(lactic-co-glycolic acid), and Silica Nanoparticles.Silk nanoparticles: proof of lysosomotropic anticancer drug delivery at single-cell resolution.Silk fibroin nanoparticles dyeing indocyanine green for imaging-guided photo-thermal therapy of glioblastoma.Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins.Manufacture and Drug Delivery Applications of Silk Nanoparticles.Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance.Production of Curcumin-Loaded Silk Fibroin Nanoparticles for Cancer Therapy.Current development of biodegradable polymeric materials for biomedical applicationsSpider silk as a blueprint for greener materials: a reviewSpider silk inspired materials and sustainability: perspectiveIn vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatmentConstruction of Self-defensive Antibacterial and Osteogenic AgNPs/Gentamicin Coatings with Chitosan as Nanovalves for Controlled releaseBioengineering the spider silk sequence to modify its affinity for drugs
P2860
Q26995026-52F11466-3994-4FE2-9121-AB58E0261D18Q27021154-8642F221-ADC0-4F26-BBC6-63F37BE1260CQ28087367-947910D5-0F89-40AC-B8F1-6A8DCD1BEEEAQ28829218-758D0CDF-026E-4198-9A48-08A88DD76D68Q33594253-FAEB792F-EE28-4D0A-9256-1ADD7F50D006Q34051924-8C6BE8F0-D9E5-4950-A2E0-2869B5737E3BQ35094256-CC53CDEF-8A73-485D-AE27-7811B9FF2EADQ35113124-959D6DF8-79BC-4978-8244-7B5B236D244BQ35598158-6C4E2F81-6BE0-4E75-BC4C-5B416FD1E1BAQ36307700-86D5885A-E203-49F7-A798-962D43F14AF7Q36490344-225234D4-8D8B-40BC-A700-B0C3807B3D33Q37014900-08EA3CCD-20ED-433A-A0C4-57FB359EBA23Q37071687-B214FB63-EBB3-4D7D-9148-905CEB2EA046Q37241907-05DB9659-A761-4DD5-8C75-EDC0DAD1EFEAQ38283340-DC86CB5E-9F00-4A29-AB9B-EE9C235AC38DQ38573478-8C9A1615-8A5F-4604-BA52-54E58E6874CFQ38733843-0F3EAD4B-BF96-4DC5-9668-1DEA4F18FC2AQ38896341-15E1FB59-3611-4C64-A998-CA617B006AB7Q41514186-81263CA3-C1D7-492F-9A37-4D61F2418EAEQ41697109-43591FA1-DF87-4AA3-BD65-95D826388D31Q47095789-A20EC768-B22A-4EFE-862A-E6B461806A6EQ47719697-3814C842-D396-415F-8E1E-08B02DBF07D8Q47984376-99B0F85A-C565-4FCE-B2BC-BB8351F99230Q48093169-80F2EBEB-ACE5-479A-A2B3-BD28E3CAF080Q48232569-041A7466-EEA0-4534-B584-E8C3244FEAC0Q49804132-2927914F-B2E9-4493-9989-F4233847934BQ50025455-F57A08D2-2A1B-4372-A9BD-81C0D2702C63Q51130202-E9E6006F-F602-48EB-ABA0-39515AF1E2F5Q53685308-6B8BE4E3-2A5D-4EBF-A9FB-42096399CFE1Q55423740-347FCBC8-6B6F-4941-83A7-1F0B66AF53ABQ57070270-9C20AD71-6715-487C-8875-5AE1F30CF2C7Q57189696-B68311A0-FAFF-4FF3-B7BF-009E04566BD3Q57189700-EA161B63-F1DC-4CB8-9005-1E6DB814CC2CQ57214335-13B206D3-7627-4FD2-AC84-CE20A371EB41Q57214357-77BED647-3FFC-47D7-81BC-D743D5F0D48BQ57214848-54D95A42-ECE6-4220-B1B3-9869813B9330
P2860
pH-dependent anticancer drug release from silk nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
pH-dependent anticancer drug release from silk nanoparticles.
@en
pH-dependent anticancer drug release from silk nanoparticles.
@nl
type
label
pH-dependent anticancer drug release from silk nanoparticles.
@en
pH-dependent anticancer drug release from silk nanoparticles.
@nl
prefLabel
pH-dependent anticancer drug release from silk nanoparticles.
@en
pH-dependent anticancer drug release from silk nanoparticles.
@nl
P2093
P2860
P356
P1476
pH-dependent anticancer drug release from silk nanoparticles.
@en
P2093
F Philipp Seib
Gregory T Jones
Jelena Rnjak-Kovacina
P2860
P304
P356
10.1002/ADHM.201300034
P577
2013-04-26T00:00:00Z